Milrinone Infusion at Home for Heart Failure: Patient Guide and Safety Overview

April 23, 2026

For patients with advanced heart failure who are not candidates for , or are awaiting , heart transplantation, continuous milrinone infusion can provide meaningful symptom relief and improved quality of life. Receiving this therapy through Pharmko's home infusion services allows patients to spend time in a familiar environment while continuing active medical management.


What Is Milrinone and How Does It Work?


Milrinone is a phosphodiesterase-3 (PDE3) inhibitor that increases the force of the heart's contractions and relaxes blood vessels to reduce cardiac workload. In advanced heart failure, it is used to:


  • Relieve symptoms of low cardiac output , fatigue, dyspnea, and poor end-organ perfusion
  • Improve functional capacity when other therapies have been maximized
  • Serve as a bridge to heart transplantation or mechanical circulatory support
  • Provide palliative symptom management for patients who are not transplant candidates


Who Is a Candidate for Home Milrinone Therapy?


Home milrinone is typically considered for patients with Stage D (end-stage) heart failure who have demonstrated clinical response to IV milrinone in a hospital setting, have a central venous access device in place, and have a stable home environment with caregiver support.


Cardiologists and heart failure specialists make this decision in collaboration with the patient and family. For families weighing this option against continued hospital care, our guide on home infusion vs. hospital infusion covers the key differences in clinical oversight, safety, and quality of life.


What Home Milrinone Therapy Involves


Continuous infusion via portable pump


Milrinone is delivered continuously , 24 hours a day , through a small, portable pump connected to the patient's central line. Pharmko delivers milrinone cassettes on a regular schedule and trains the patient and caregiver on pump management. For an overview of the equipment involved, see our guide on infusion pumps and supplies.


Central line care


Because milrinone is delivered through a central line, meticulous line care is essential. Pharmko's nurses provide hands-on training in dressing changes, flushing protocols, and infection warning signs. Our full guide on central line care at home covers the key daily habits that reduce CLABSI risk.


Monitoring and clinical check-ins


Pharmko's nursing team conducts scheduled home visits and phone check-ins, and is available through our 24/7 after-hours support line for urgent questions. Know which symptoms should trigger an immediate call , especially changes in fluid status, arrhythmias, or line site concerns.


Life Expectancy and Quality of Life on Home Milrinone


Milrinone does not reverse heart failure or extend life expectancy in the same way that disease-modifying therapies do. However, for patients with end-stage disease, home milrinone can significantly improve functional status , allowing patients to be more active, spend time with family, and avoid repeated hospitalizations. The decision to continue or discontinue milrinone is an ongoing conversation between the patient, family, and medical team.


Starting Home Milrinone Therapy with Pharmko


Pharmko works with cardiologists and heart failure programs across 23 states. View our full service area coverage or reach our referral team for providers for time-sensitive discharge coordination.

Contact Pharmko: 1-877-549-3863 · info@pharmko.com

Home Infusion for Crohn's Disease: Remicade, Biologics, and What Patients Should Know
April 23, 2026
Learn how home infusion therapy for Crohn's disease works, including Remicade (infliximab) and other biologics. Who qualifies, what each infusion involves, and how Pharmko supports ongoing care.
Malnutrition in Hemodialysis Patients: Signs, Risks, and When IDPN Is Needed
April 23, 2026
Malnutrition affects up to 75% of hemodialysis patients. Learn to recognize protein-energy wasting, understand when IDPN is clinically indicated, and how Pharmko supports renal nutrition management.
IDPN Therapy: Who Qualifies, How It Works, and What to Expect
April 23, 2026
Learn how intradialytic parenteral nutrition (IDPN) works, who qualifies based on albumin levels and nutritional status, and how Pharmko delivers IDPN for dialysis patients.
How to Refer a Patient to Home Infusion Therapy: A Guide for Providers
April 17, 2026
Step-by-step guide for physicians, discharge planners, and case managers on how to refer a patient to home infusion therapy. Learn the process, documentation needed, and what to expect from Pharmko.
Home Infusion vs. Hospital Infusion: Is Receiving IV Therapy at Home Safe?
April 17, 2026
Wondering if home infusion therapy is as safe as hospital infusion? Compare both options, understand the clinical safeguards, and learn when home IV therapy is the right choice.
IVIG Therapy at Home: What Patients Need to Know Before Starting
April 17, 2026
Considering IVIG therapy at home? Learn who qualifies, how home IVIG infusions work, what to expect during treatment, and how Pharmko supports you every step of the way.
Home IV Antibiotics: How to Receive IV Antibiotic Therapy at Home
April 17, 2026
Learn how home IV antibiotic therapy works, who qualifies, what to expect, and how Pharmko supports your treatment from day one. 24/7 clinical support across 23 states.
Home Infusion Binder: Organize Orders, Contacts, and Questions in One Place
April 1, 2026
Learn how to organize home infusion therapy details in one place orders, contacts, supply notes, symptoms, and questions so support is faster and clearer.
Work and School While on Home Infusion: Scheduling, Planning, and What to Ask For
April 1, 2026
Learn how to plan work or school while on home infusion—routine scheduling, communication tips, and what to ask your care team for support.
Comfort During Long Home Infusions: How to Plan Your Setup and Feel Better
April 1, 2026
Learn how to plan comfort during long home infusions—setup, positioning, pacing, and what to track so your care team can support you.
Show More